Sonolysis promotes indirect Co-C bond cleavage of alkylcob(III)alamin bioconjugates.
Sonolysis promotes indirect Co-C bond cleavage of alkylcob(III)alamin bioconjugates.
复制标题
Sonolysis 促进烷基钴 (III) 胺生物共轭物的间接 Co-C 键裂解。
DOI:
10.1021/bc970077l
复制
发表时间:
1997
期刊:
影响因子:
--
通讯作者:
West,FG
中科院分区:
文献类型:
--
作者:
HowardJr,WA;Bayomi,A;Natarajan,E;Aziza,MA;el-Ahmady,O;Grissom,CB;West,FG
Sonolysis of aqueous solutions produces H·and HO·that lead to Co−C bond cleavage in methylcob(III)alamin (CH3-CblIII) and 2-[4-[4‘-[bis(2-chloroethyl)amino]phenyl]butyroxy]ethylcob(III)alamin (Chl-HE-CblIII). Under anaerobic conditions, H·reduces CH3-CblIIIto the unstable 19 e-CH3-CblIIthat dissociates to the alkane and CblII. Under aerobic conditions, O2scavenges H·and Co−C bond cleavage occurs via a HO·-mediated process along with modification of the corrin ring by HO·. When H·and HO·are scavenged, there is no evidence of Co−C bond cleavage. This suggests no direct sonolysis of the Co−C bond occurs, in spite of the fact that the Co−C bond is 80 kcal/mol weaker than the H−OH bond. A bioconjugate of cob(III)alamin and the alkylating agent chlorambucil has been synthesized to give 2-[4-[4‘-[bis(2-chloroethyl)amino]phenyl]butyroxy]ethylcob(III)alamin. The chlorambucil−cobalamin complex also undergoes Co−C bond cleavage in a manner similar to that of methylcob(III)alamin. Sonorelease of an active alkylating agent from the bioconjugate may provide a new method for the selective release of anticancer drugs and thus potentially reduce systemic toxicity.